Sign in to continue:

Saturday, April 25th, 2026

SenseTime Completes HK$3.23 Billion Placing of 1.7 Billion New Class B Shares Under General Mandate

SenseTime Group Inc. Completes Major Placing of New Class B Shares

SenseTime Group Inc. Completes Major Placing of New Class B Shares Under General Mandate

Key Highlights of the Announcement

  • Placing Completion: SenseTime Group Inc. has successfully completed the placing of new Class B Shares under its general mandate. The placing was finalized on April 24, 2026, following the fulfillment of all conditions set out in the Placing Agreement.
  • Scale of the Placing: A total of 1,700,000,000 new Class B Shares were placed at HK\$1.91 per share. The shares were sold to no fewer than six placees, all of whom are independent third parties. This placement represents approximately 4.25% of issued Class B Shares and 4.20% of total issued shares prior to completion, and around 4.08% and 4.03% respectively after the completion and enlargement of the share base.
  • Net Proceeds: The company raised approximately HK\$3,230 million in net proceeds after deducting relevant costs, commissions, and expenses.
  • Shareholding Structure Changes: Following the completion, the total number of issued shares increased to 42,216,590,703, comprising 509,844,373 Class A Shares and 41,706,746,330 Class B Shares. None of the placees became a substantial shareholder as defined under the Listing Rules.
  • Regulatory Filings: The company will make the necessary filings with PRC regulatory authorities, including the China Securities Regulatory Commission (CSRC), in accordance with applicable laws and regulations.
  • Public Float Maintained: The Directors confirmed that the public float post-placing remains above 25%, in compliance with listing requirements.

Details and Implications for Shareholders

The successful placement of 1.7 billion new Class B Shares is a significant event for SenseTime Group Inc. investors. The offering, which was not open to the public in the United States and was conducted in accordance with international securities regulations, brings in substantial new capital that could be directed toward business growth, innovation, or strategic acquisitions—though the specific intended use of proceeds was detailed in prior disclosure (see the original placing announcement for those details).

Importantly, the placing did not result in any of the new investors (placees) becoming a substantial shareholder, meaning that control of the company remains unchanged amongst existing major shareholders. This could be reassuring for investors concerned about potential large-scale shifts in ownership or control.

The dilution effect is relatively modest: the placement increased the total share base by approximately 4.2%. For investors, this means a slightly reduced proportionate ownership unless they participated in the placement. However, the infusion of HK\$3.23 billion in new funds strengthens the company’s balance sheet, providing financial flexibility for future development and operational needs.

Shareholders should also note that the company remains compliant with the 25% minimum public float requirement, which supports continued liquidity and trading activity for the shares.

Potential Price Sensitive Information

  • Large Capital Raise: The successful placement and significant net proceeds could be seen as a positive signal of market confidence in the company and may support future growth initiatives.
  • Share Dilution: The increase in share capital causes some dilution to existing shareholders, which could have a short-term impact on share price. However, this may be offset by the strategic use of the new funds raised.
  • No Major Change in Control: The placing did not result in any new substantial shareholders, maintaining stability in the company’s governance and ownership structure.
  • Regulatory Compliance: Ongoing compliance with listing and regulatory requirements ensures stability and continued eligibility for trading on the Hong Kong Stock Exchange.

Additional Corporate Governance Information

The board of directors remains unchanged, with Dr. Xu Li serving as Executive Chairman and CEO. The composition ensures continuity in leadership and oversight.

Disclaimer

The information provided above is based on the company’s official announcement dated April 24, 2026. This article does not constitute investment advice. Investors should conduct their own research and consider their own financial situation and investment objectives before making any investment decisions. The company’s future performance and share price may be affected by a range of factors, including but not limited to the effective deployment of the funds raised, market conditions, and regulatory developments.


View SENSETIME-W
SENSETIME-WR Historical chart here



   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today